Garlipp B, Seidensticker M, Jechorek D, Ptok H, Bruns C J, Ricke J
Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Deutschland.
Klinik für Radiologie und Nuklearmedizin, Universitätsklinikum Magdeburg, Magdeburg, Deutschland.
Chirurg. 2016 May;87(5):380-8. doi: 10.1007/s00104-016-0154-9.
Preservation of an adequate future liver remnant (FLR) is the principal limitation to liver surgery in patients with primary or secondary liver malignancies. Hence, methods to increase the volume of the FLR in preparation for liver resection are gaining in importance.
In addition to the traditional methods for induction of FLR hypertrophy, such as portal vein embolization (PVE) or portal vein ligation (PVL) with or without parenchymal dissection (ALPPS, in situ split), radioembolization (RE) using yttrium-90 microspheres also leads to a volume increase of non-embolized liver parenchyma. This review outlines its potential role as an alternative procedure for induction of liver hypertrophy.
Synopsis and critical discussion of the available literature on the mechanisms of induction of liver hypertrophy, the advantages and drawbacks of the traditional methods, and current research on volume changes associated with RE as well as their implications for possible clinical use in preparation for liver surgery.
Both PVE and PVL can achieve a substantial contralateral volume gain of up to 70 %. The development of contralateral hypertrophy can be accelerated by dissecting the liver parenchyma along the intended plane of resection in addition to PVL (in situ split). Compared to these methods, RE achieves less contralateral liver hypertrophy; however, this effect should not be disregarded as RE provides effective treatment of ipsilateral liver tumors along with induction of hypertrophy and may be associated with a reduced risk of tumor progression compared to PVE and PVL.
The available data suggest that RE can complement the armamentarium of methods for induction of FLR hypertrophy in specific situations. Further studies are needed to establish its definitive role for this indication and are in preparation.
保留足够的未来肝残余量(FLR)是原发性或继发性肝恶性肿瘤患者肝脏手术的主要限制因素。因此,在准备肝切除时增加FLR体积的方法变得越来越重要。
除了诱导FLR肥大的传统方法,如门静脉栓塞(PVE)或门静脉结扎(PVL),无论有无实质解剖(ALPPS,原位劈离),使用钇-90微球的放射性栓塞(RE)也会导致未栓塞肝实质体积增加。本综述概述了其作为诱导肝肥大替代方法的潜在作用。
对现有文献进行概述和批判性讨论,内容包括肝肥大诱导机制、传统方法的优缺点、当前关于RE相关体积变化的研究及其对肝手术准备中可能临床应用的影响。
PVE和PVL均可使对侧肝实质体积显著增加,增幅可达70%。除PVL外,沿预期切除平面进行肝实质解剖(原位劈离)可加速对侧肝肥大的发展。与这些方法相比,RE导致的对侧肝肥大程度较小;然而,这一效果不应被忽视,因为RE在诱导肝肥大的同时可有效治疗同侧肝肿瘤,且与PVE和PVL相比,其肿瘤进展风险可能降低。
现有数据表明,在特定情况下,RE可补充诱导FLR肥大方法的手段。需要进一步研究以确定其在该适应证中的明确作用,相关研究正在进行中。